Coca-Cola (KO), Procter & Gamble (PG) and Colgate-Palmolive (CL), three long-tenured Dividend Kings in the U.S. consumer staples space, have pushed to fresh 52-week highs following the midterm elections, as political uncertainty drives investors toward stable, defensive assets. The run-up has pushed valuations for all three firms into premium territory, narrowing their long-term upside for shareholders.
Democrats’ takeover of both Congress and the Senate has created a divided government dynamic, stoking broad expectations of prolonged legislative gridlock on Capitol Hill. Most market participants view consumer staples names as largely insulated from political shifts, since household essentials from beverages to oral care products remain in steady demand regardless of which party controls legislative power. All three companies qualify as Dividend Kings, a designation for firms with at least 50 consecutive years of annual dividend increases. Their decades-long payout track records, paired with recent quarterly earnings results, have made them top destinations for investors seeking shelter from market volatility.
Coca-Cola delivered a standout quarterly performance that underscored the resilience of its beverage franchise. Revenue rose 7% year over year, while comparable earnings per share jumped 11%, driven by solid volume growth and ongoing price increases. The strong quarter prompted the company to lift its full-year guidance, and it now projects comparable EPS growth of no less than 11%, or roughly $3.33 per share. Following the election, shares of Coca-Cola traded around $96, putting the stock at nearly 29 times earnings — well above the S&P 500’s current multiple of about 23.5 times.
Procter & Gamble has been navigating dual headwinds from elevated costs and softening demand. In its fiscal 2027 first quarter, the consumer products giant posted 4% growth in net sales, with core EPS edging up just 1%. The company expects persistent cost pressures to weigh on results for the full year, forecasting midpoint core EPS growth of roughly 1.5% to about $7 per share. Higher raw material, energy and transportation costs are expected to create an 11 percentage-point drag on EPS this year. With shares trading above $167, Procter & Gamble carries a price-to-earnings ratio of nearly 24 times. While the multiple is not out of line for a company of its quality, it leaves little margin of safety if growth stays muted.
Colgate-Palmolive turned in a comparatively strong quarter among peer consumer products firms. Net sales climbed 4.6%, and base business EPS advanced 7%, with the company reporting improving profit margins through the period. The better-than-expected performance led Colgate to raise its full-year base business EPS growth forecast to a range of 5% to 7%, with a midpoint of roughly $3.91 per share. At nearly $99 per share, the stock trades at more than 25 times earnings, leaving little valuation upside for new buyers.
Over the long term, large consumer staples companies typically deliver mid-to-high single-digit annual growth in core EPS. Combined with their dividend payouts, they can generate total returns approaching double digits if their valuation multiples hold steady. Maintaining those premium multiples, however, will prove challenging if earnings growth falls short of expectations, and multiple compression could leave investors with lackluster returns. Conservative projections show that a $10,000 investment in each stock today would grow to roughly $11,909 for Coca-Cola, $12,819 for Procter & Gamble and $13,166 for Colgate-Palmolive over five years — a relatively modest return profile with limited room for error.
All three companies generate robust cash flows from essential consumer products and boast lengthy track records of dividend growth. Procter & Gamble has raised its payout for 70 consecutive years, while Coca-Cola and Colgate-Palmolive hold streaks of 64 and 63 years respectively. Yet a strong business does not equal a strong investment at any price. With dividend yields ranging from 2.2% to 2.6% and stretched earnings multiples, elevated valuations are already pricing in much of their future growth. Market analysis suggests investors would be better served waiting for more attractive entry points rather than chasing the stocks at their recent highs.